Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
pepsgpt.com
Samples
Passed
Failed
Trust score updated: June 22, 2026 · 100% pass rate
Composite score based on 67 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of the safety panels each product form requires — identity, net-content, heavy-metals and residual-solvents for raw powders, plus endotoxin and sterility for injectables. Forms aren't penalized for panels they don't need.
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| May 16, 2026 | BPC-157 | HPLC purity | PASS | 99.36% | Horizon Analytical | Lot P-7454331-P |
| May 12, 2026 | GLOW | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-9377026-E · Report P-9377026-E |
| May 12, 2026 | BPC-157 | HPLC purity | PASS | 99.45% | Horizon Analytical | Lot P-9377026-P · Report P-9377026-P |
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v14). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 67 COAs attributed to this vendor. Last recomputed 2026-06-22.
| May 12, 2026 | Tirzepatide | HPLC purity | PASS | 99.29% | Horizon Analytical | Lot P-9887337-P · Report P-9887337-P |
| May 12, 2026 | Tirzepatide | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-9887337-E · Report P-9887337-E |
| May 11, 2026 | AOD-9604 | HPLC purity | PASS | 99.65% | Horizon Analytical | Lot P-3713888-P · Report P-3713888-P |
| May 11, 2026 | AOD-9604 | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-3713888-E · Report P-3713888-E |
| May 10, 2026 | BPC-157 + TB-500 | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-2917829-E · Report P-2917829-E |
| May 10, 2026 | BPC-157 | HPLC purity | PASS | 99.26% | Horizon Analytical | Lot P-2917829-P · Report P-2917829-P |
| May 9, 2026 | Tirzepatide | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-3795846-E · Report P-3795846-E |
| May 8, 2026 | NAD+ | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-1630816-E |
| May 8, 2026 | BPC-157 | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-3548854-E |
| May 8, 2026 | BPC-157 | HPLC purity | PASS | 99.24% | Horizon Analytical | Lot P-3548854-P · Report P-3548854-P |
| May 8, 2026 | GHK-Cu | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-5920245-E · Report P-5920245-E |
| May 8, 2026 | Tirzepatide | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-3038615-E · Report P-3038615-E |
| May 8, 2026 | NAD+ | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-7932744-E · Report P-7932744-E |
| May 8, 2026 | NAD+ | HPLC purity | PASS | 99.39% | Horizon Analytical | Lot P-7932744-P · Report P-7932744-P |
| May 8, 2026 | Thymosin Alpha-1 | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-1947064-E · Report P-1947064-E |
| May 8, 2026 | Retatrutide | HPLC purity | PASS | 99.33% | Horizon Analytical | Lot P-9490216-P · Report P-9490216-P |
| May 8, 2026 | Semax | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-1902514-E · Report P-1902514-E |
| May 8, 2026 | Retatrutide | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-9490216-E · Report P-9490216-E |
| May 8, 2026 | Kisspeptin-10 | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-8975198-E · Report P-8975198-E |
| May 8, 2026 | L-Glutathione | HPLC purity | PASS | 99.41% | Horizon Analytical | Lot P-3871218-P · Report P-3871218-P |
| May 8, 2026 | GHK-Cu | HPLC purity | PASS | 99.46% | Horizon Analytical | Lot P-5920245-P · Report P-5920245-P |
| May 8, 2026 | Hexarelin | HPLC purity | PASS | 99.19% | Horizon Analytical | Lot P-7132129-P · Report P-7132129-P |
| May 8, 2026 | Hexarelin | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-7132129-E · Report P-7132129-E |
| May 8, 2026 | L-Glutathione | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-3871218-E · Report P-3871218-E |
| May 8, 2026 | NAD+ | HPLC purity | PASS | 99.51% | Horizon Analytical | Lot P-1630816-P · Report P-1630816-P |
| May 6, 2026 | Oxytocin | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-4275312-E · Report P-4275312-E |
| May 6, 2026 | Oxytocin | HPLC purity | PASS | 99.41% | Horizon Analytical | Lot P-4275312-P · Report P-4275312-P |
| May 5, 2026 | MOTS-c | HPLC purity | PASS | 99.39% | Horizon Analytical | Lot P-4301315-P · Report P-4301315-P |
| May 4, 2026 | Selank | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-2406449-E · Report P-2406449-E |
| May 4, 2026 | Ipamorelin + CJC-1295 | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-3437208-E · Report P-3437208-E |
| May 4, 2026 | GHK-Cu | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-9250030-E |
| May 4, 2026 | Ipamorelin | HPLC purity | PASS | 99.28% | Horizon Analytical | Lot P-3437208-P · Report P-3437208-P |
| May 4, 2026 | GHK-Cu | HPLC purity | PASS | 99.51% | Horizon Analytical | Lot P-9250030-P · Report P-9250030-P |
| May 3, 2026 | Tesamorelin | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-7980975-E · Report P-7980975-E |
| May 3, 2026 | Semaglutide | HPLC purity | PASS | 99.23% | Horizon Analytical | Lot P-2885342-P · Report P-2885342-P |
| May 3, 2026 | PT-141 | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-2061592-E · Report P-2061592-E |
| May 3, 2026 | Tesamorelin | HPLC purity | PASS | 99.19% | Horizon Analytical | Lot P-7980975-P · Report P-7980975-P |
| May 3, 2026 | Melanotan 2 MT-2 | HPLC purity | PASS | 99.15% | Horizon Analytical | Lot P-7423137-P · Report P-7423137-P |
| May 3, 2026 | Melanotan 2 (MT-2) | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-7423137-E |
| May 3, 2026 | PT-141 | HPLC purity | PASS | 99.25% | Horizon Analytical | Lot P-2061592-P · Report P-2061592-P |
| May 1, 2026 | Semax | HPLC purity | PASS | 99.18% | Horizon Analytical | Lot P-1902514-P · Report P-1902514-P |
| Apr 30, 2026 | Kisspeptin-10 | HPLC purity | PASS | 99.26% | Horizon Analytical | Lot P-8975198-P · Report P-8975198-P |
| Apr 30, 2026 | BPC-157 | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-4900644-E · Report P-4900644-E |
| Apr 30, 2026 | BPC-157 | HPLC purity | PASS | 99.39% | Horizon Analytical | Lot P-4900644-P · Report P-4900644-P |
| Apr 26, 2026 | Selank | HPLC purity | PASS | 99.37% | Horizon Analytical | Lot P-2406449-P · Report P-2406449-P |
| Apr 26, 2026 | Semaglutide | Identity & safety panels | PASS | -- | Horizon Analytical | Lot P-2885342-E · Report P-2885342-E |
| Apr 26, 2026 | Thymosin Alpha-1 | HPLC purity | PASS | 99.32% | Horizon Analytical | Lot P-1947064-P · Report P-1947064-P |